Tsakmaki Anastasia, Fonseca Pedro Patricia, Bewick Gavin A
Faculty of Life Sciences and Medicine, School of Life Course Sciences, Department of Diabetes, Diabetes Research Group, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK.
Diabetologia. 2020 Jun;63(6):1093-1102. doi: 10.1007/s00125-020-05126-3. Epub 2020 Mar 27.
Diabetes is one of the most challenging health concerns facing society. Available drugs treat the symptoms but there is no cure. This presents an urgent need to better understand human diabetes in order to develop improved treatments or target remission. New disease models need to be developed that more accurately describe the pathology of diabetes. Organoid technology provides an opportunity to fill this knowledge gap. Organoids are 3D structures, established from pluripotent stem cells or adult stem/progenitor cells, that recapitulate key aspects of the in vivo tissues they mimic. In this review we briefly introduce organoids and their benefits; we focus on organoids generated from tissues important for glucose homeostasis and tissues associated with diabetic complications. We hope this review serves as a touchstone to demonstrate how organoid technology extends the research toolbox and can deliver a step change of discovery in the field of diabetes.
糖尿病是社会面临的最具挑战性的健康问题之一。现有的药物只能治疗症状,无法治愈。因此,迫切需要更好地了解人类糖尿病,以便开发出改进的治疗方法或实现疾病缓解。需要开发更准确描述糖尿病病理的新疾病模型。类器官技术为填补这一知识空白提供了契机。类器官是由多能干细胞或成体干/祖细胞形成的三维结构,能够重现它们所模拟的体内组织的关键特征。在这篇综述中,我们简要介绍类器官及其优势;重点关注由对葡萄糖稳态重要的组织以及与糖尿病并发症相关的组织生成的类器官。我们希望这篇综述能成为一块试金石,展示类器官技术如何扩展研究工具箱,并在糖尿病领域带来突破性的发现。